nL-LMNB1-001

N/A

Report date: 2025/02/13 20:00:05
NME

Base Information

Drug NamenL-LMNB1-001
Drug Alias NamenL-LMNB1-001
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukoencephalopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesN-Lorem Foundation
China Registration ClassN/A

Develop Information

Active CompaniesN-Lorem Foundation
Inactive CompaniesN/A
Active IndicationsLeukoencephalopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A